PRP guidelines · International

Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial

Jose Ignacio Martin, Leire Atilano, Josu Merino, Igor Gonzalez, Gotzon Iglesias, Luis Areizaga, Paola Bully 4, Gonzalo Grandes, Isabel Andia

Journal of Orthopaedic Surgery and Research · 2019

In brief

This double-blind randomised trial looked at people with stubborn elbow tendinopathy who had ultrasound-guided tendon needling combined with either platelet-rich plasma (PRP) or lidocaine, a local anaesthetic. The authors found that both groups improved similarly over a year, with no clear advantage for PRP, and suggest careful patient selection may matter more.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Platelet-rich plasma versus lidocaine as tenotomy adjuvants in people with elbow epicondylopathy: a randomized controlled trial Authors: Jose Ignacio Martin, Leire Atilano, Josu Merino, Igor Gonzalez, Gotzon Iglesias, Luis Areizaga, Paola Bully 4, Gonzalo Grandes, Isabel Andia Link: https://www.ncbi.nlm.nih.gov/pubmed/31014382 Year of Publication: 2019

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.